J.M. Extra
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Neutropenia and Cancer Infections
Papers in ⓘ
-
- Breast Cancer Treatment Studies 10
- Cancer Genomics and Diagnostics 6
- Oncology 22
- Cancer Treatment and Pharmacology 14
- Cancer Cells and Metastasis 4
- Cancer Diagnosis and Treatment 3
- Neutropenia and Cancer Infections 3
- Co-authors
- Marc Espié (10 shared papers)M. Marty (9 shared papers)Sylvie Giacchetti (5 shared papers)Véronique Dièras (4 shared papers)F. Morvan (5 shared papers)L. Mignot (3 shared papers)J-Y Pierga (3 shared papers)E. Bourstyn (7 shared papers)
In The Last Decade
J.M. Extra
32 papers receiving 404 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 175
- Oncology 306
- Pathology and Forensic Medicine 101
- Dermatology 41
- Genetics 31
Countries citing papers authored by J.M. Extra
This map shows the geographic impact of J.M. Extra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Extra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Extra more than expected).
Fields of papers citing papers by J.M. Extra
This network shows the impact of papers produced by J.M. Extra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Extra. The network helps show where J.M. Extra may publish in the future.
Co-authors
The 25 scholars most cited alongside J.M. Extra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 64 | |
| 2 | 1994 | 61 | |
| 3 | 1986 | 54 | |
| 4 | Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience. | 1995 | 33 |
| 5 | 1992 | 24 | |
| 6 | Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer. | 1996 | 24 |
| 7 | 2009 | 23 | |
| 8 | 2014 | 20 | |
| 9 | 2004 | 15 | |
| 10 | 1991 | 12 | |
| 11 | 1994 | 10 | |
| 12 | 1999 | 10 | |
| 13 | 1997 | 10 | |
| 14 | 1996 | 9 | |
| 15 | 1999 | 9 | |
| 16 | 2013 | 8 | |
| 17 | 2004 | 6 | |
| 18 | 2001 | 6 | |
| 19 | 2001 | 4 | |
| 20 | [Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast]. | 1993 | 4 |
About J.M. Extra
J.M. Extra is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Pathology and Forensic Medicine and Internal Medicine, having authored 33 papers that have together received 430 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (10 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Cells and Metastasis (4 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Diagnosis and Treatment (3 papers), Neutropenia and Cancer Infections (3 papers) and Breast Lesions and Carcinomas (3 papers). The work is most often cited by research in Cancer Research (175 citations), Oncology (306 citations), Pathology and Forensic Medicine (101 citations), Dermatology (41 citations) and Genetics (31 citations). J.M. Extra has collaborated with scholars based in France, Sweden and Japan. Frequent co-authors include Marc Espié, M. Marty, Sylvie Giacchetti, Véronique Dièras, F. Morvan, L. Mignot, J-Y Pierga, E. Bourstyn, Éric Bellissant and Patricia Tresca. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, European Journal of Cancer, Annals of Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.